News headlines about athenahealth (NASDAQ:ATHN) have trended somewhat positive this week, according to Accern Sentiment. The research group identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. athenahealth earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned press coverage about the health services provider an impact score of 46.0604353892568 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
ATHN has been the subject of several analyst reports. Robert W. Baird lowered their target price on shares of athenahealth from $170.00 to $155.00 and set an “outperform” rating for the company in a report on Sunday, October 22nd. TheStreet downgraded shares of athenahealth from a “b-” rating to a “c+” rating in a report on Wednesday, October 11th. First Analysis upgraded shares of athenahealth from an “underweight” rating to an “equal weight” rating and increased their target price for the company from $125.00 to $127.00 in a report on Monday, October 23rd. Leerink Swann set a $155.00 target price on shares of athenahealth and gave the company a “hold” rating in a report on Thursday, October 19th. Finally, Jefferies Group LLC lowered their target price on shares of athenahealth from $135.00 to $120.00 and set a “hold” rating for the company in a report on Friday, September 15th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and eleven have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $143.22.
athenahealth (NASDAQ ATHN) opened at $124.16 on Wednesday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.67 and a quick ratio of 1.67. athenahealth has a 1 year low of $90.11 and a 1 year high of $158.66. The company has a market cap of $5,025.02, a P/E ratio of 106.42, a PEG ratio of 5.05 and a beta of 1.57.
In other news, SVP Bradford Kyle Armbrester sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, October 27th. The shares were sold at an average price of $128.56, for a total value of $128,560.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Jonathan D. Porter sold 300 shares of the firm’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $130.38, for a total transaction of $39,114.00. The disclosure for this sale can be found here. Insiders sold 12,483 shares of company stock valued at $1,637,372 over the last 90 days. 3.20% of the stock is owned by company insiders.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.